SCHEMBL6178012

SCHEMBL6178012

Cc1ccc(S(=O)(=O)N2CCCC2c2cccnc2)cc1O

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.62
CYP2C19 P33261 1/20 0.62
ALDH1A1 P00352 6/20 0.62
USP2 O75604 1/20 0.62
POLB P06746 3/20 0.61
ADRB2 P07550 3/20 0.60
TSHR P16473 1/20 0.60
MAPT P10636 6/20 0.57
LMNA P02545 3/20 0.57
KMT2A Q03164 1/20 0.54
MAPK1 P28482 2/20 0.52
HTT P42858 2/20 0.52
TP53 P04637 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
KDM4E B2RXH2 1/20 0.51
THRB P10828 1/20 0.49
CHRNA7 P36544 2/20 0.48
CHRNB2 P17787 2/20 0.48
CHRNB4 P30926 2/20 0.48
CHRNA3 P32297 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6178979 0.87 PSEN1 (0.57) CYP3A4CYP2C19ALDH1A1USP2POLB
SCHEMBL6178010 0.84 CYP3A4 (0.74) CYP3A4CYP2C19ALDH1A1USP2POLB
SCHEMBL6180591 0.84 TRPA1 (0.48) CYP3A4CYP2C19ALDH1A1USP2POLB
SCHEMBL6179184 0.82 TRPA1 (0.57) POLBMAPTLMNAMAPK1KDM4E
SCHEMBL3367394 0.81 NPSR1 (0.49) CYP3A4CYP2C19ALDH1A1USP2POLB
SCHEMBL6178185 0.78 TRPA1 (0.53) ALDH1A1POLBMAPTLMNAKDM4E
SCHEMBL6180434 0.78 TRPA1 (0.47) LMNATRPA1
SCHEMBL24016026 0.78 CYP3A4 (0.66) CYP3A4CYP2C19ALDH1A1USP2POLB
SCHEMBL26465275 0.78 CYP3A4 (0.66) CYP3A4CYP2C19ALDH1A1USP2POLB
SCHEMBL24015601 0.78 CYP3A4 (0.66) CYP3A4CYP2C19ALDH1A1USP2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1165510-B1 1-ARENESULFONYL-2-ARYL-PYRROLIDINE AND PIPERIDINE DERIVATIVES FOR THE TREATMENT OF CNS DISORDERS HOFFMANN LA ROCHE (CH) 2005-09-28 EP claimed